.svg){kind=icon}
AI in clinical research isn’t just hype—it’s happening. But how can sponsors, CROs, and clinical teams integrate it strategically and responsibly without compromising compliance?
In this episode, Kelly Roland returns to The Clinical Current to go beyond the headlines and break down what today’s leaders should be paying attention to.
We unpack real-world implications from:
✅ America’s AI Action Plan
✅ McKinsey’s Gen AI: A Game Changer for Biopharma Operations
✅ Microsoft’s Work Trend Index
✅ Matt Britton’s Generation AI
🎯 Key topics include:
Risk-based monitoring in an AI-driven world
The evolving regulatory landscape
The rise of “Frontier Firms” and what they mean for pharma
Practical strategies for AI adoption with inspection readiness in mind
If you're navigating clinical trials, operations, or digital transformation, this conversation is for you.
🔗 Don’t forget to subscribe for more insight-driven episodes from The Clinical Current
